Pfizer Starts Human Trials of Potential CCP Virus Vaccines

Scientists work at Pfizer's Vaccine Research and Development Hub in Pearl River, New York, in an undated photograph. Pfizer via The Epoch Times

Human trials on potential CCP virus vaccines produced by Pfizer started in recent days, the company announced on May 5.

Researchers around the world are racing to develop a vaccine for the CCP (Chinese Communist Party) virus, but few are in human trials.